Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

ScienceInsider reports that the French National Assembly approved a new law on Tuesday that could facilitate researchers’ ability to work with human embryos and embryonic stem cells.  

The existing law did allow French researchers to do some work with embryos, but was restrictive and required researchers to apply for permission to work with embryos; scientists had to show regulators that there was no other source of cells for their experiments and that the work could yield important medical discoveries. Proponents of the new law say the existing permit process enabled opponents of embryonic work to block research proposals; critics argue that the 190 approved applications between 2004 and 2012 demonstrate the old law was not a real hindrance, reports ScienceInsider.

An American company, Advanced Cell Technology, is currently testing retinal cells derived from human embryonic stem cells as a treatment for degenerative eye diseases in the U.S. and the U.K.

1 comment. Share your thoughts »

Tagged: Biomedicine, stem cells, regenerative medicine

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me